Partner with MaxCyte for comprehensive cell engineering expertise, with industry-leading Flow Electroporation technology at the core.
Which electroporator is right for you?
Instrument comparison guide
MaxCyte’s unique electroporation technology was designed for safe, efficient and reproducible transfection to enable the development and manufacturing of next generation cell therapies. We’re here to help you transfect virtually any cell type for any application, at any scale. Empower your research with our ExPERT™ instruments.
|Performance||High efficiency and viability||High efficiency and viability||High efficiency and viability||High efficiency and viability|
|Scale (cells)||75 Thousand to 700 Million||75 Thousand to 20 Billion||75 Thousand to 20 Billion||75 Thousand to 200 Billion|
|Protocols||Configurable to desired need||Configurable to desired need||Configurable to desired need||Configurable to desired need|
|User Interface||Touch screen||Touch screen||Touch screen||Touch screen|
|Operating System||Windows IoT (1809 LTSC)||Windows IoT (1809 LTSC)||Windows IoT (1809 LTSC)||Windows IoT (1809 LTSC)|
|LED Status Indicator|
|Master File||Need to upgrade to ExPERT GTx||Need to upgrade to ExPERT GTx|
|cGMP||Manufactured under ISO 9001/cGMP||Manufactured under ISO 9001/cGMP||Manufactured under ISO 9001/cGMP||Manufactured under ISO 9001/cGMP|
|21 CFR part 11|
|Support||Yes – includes software updates|
Choosing MaxCyte gives you more than just an instrument —you get a partner with the knowledge to support you during every stage of your journey of discovery.
Efficiency, Productivity and Efficacy
Your voyage to discovery
Scalable Electroporation of Adult Keratinocytes with Multiplexed CRISPR Ribonucleoproteins for the Development of Novel Cell Therapeutics
Ex Vivo Gene Correction in X-CGD Patient Stem Cells
Engineering NK Cells with High-Affinity CD16 for Enhanced Combination Therapy to Treat B-Cell Lymphoma
Transfect any molecule with MaxCyte's platform technology
Our ExPERT range of instruments deliver consistent performance from day one. MaxCyte’s electroporation technology can efficiently and reproducibly deliver a large diversity of payloads into virtually any eukaryotic cell type.
From Concept to Clinic with One Line of Consumables
Simplify your research and move novel therapies to the clinic faster using MaxCyte’s range of consumables designed to work at any scale from 75 thousand cells to 200 billion cells.